Back to Agenda
Pharmaceuticals and Medical Devices Agency (PMDA) Town Hall
Session Chair(s)
Nobumasa Nakashima
Professor, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Japan
Representatives from the Pharmaceuticals and Medical Devices Agency (PMDA) will explain its current services and the Japanese drug regulation, and answer your questions on PMDA’s future initiatives/challenges for faster review and better life cycle management of drugs.
Please come prepared with your questions for the PMDA Town Hall panel. You may submit questions and topics of interest in advance to annualmeetingprogram@diahome.org, and include “PMDA Town Hall” in the subject line.
Learning Objective : Discuss the current situation of PMDA and Japanese regulation; Communicate with PMDA senior officials on Japanese drug regulatory issues.
Speaker(s)
Tatsuya Kondo, MD, PHD
President, SH Medical Excellence JAPAN, Japan
Future Plan of PMDA for the Next Five Years
Masaru Hiraiwa
Director, Office of Planning and Coordination, Pharmaceuticals and Medical Devices Agency (PMDA), Japan
Introduction of the Third 5-Year Mid-Term Plan of PMDA
Tetsuo Nagano, PHD
Executive Director, Pharmaceuticals and Medical Devices Agency (PMDA), Japan
PMDA's Efforts in the Medical Area
Hiroshi Yamamoto, MS
Chief Safety Officer, Pharmaceuticals and Medical Devices Agency (PMDA), Japan
Safety Measures: The Risk Management Plan in Japan
Have an account?